Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board; Notice of Meetings, 19188-19189 [2011-8114]

Download as PDF 19188 Federal Register / Vol. 76, No. 66 / Wednesday, April 6, 2011 / Notices Analysis (OEA) independently reviewed the FHWA EA, OEA prepared and issued on January 28, 2010, a Review of Environmental Matters and Final Environmental Recommendations in which OEA recommended that the Board adopt the FHWA EA and impose the 3 environmental conditions recommended by the FHWA. Due to a subsequent proposed change by the City in project design and in the rail alignment, OEA, the FHWA, the Iowa Department of Transportation, and the City conducted a reevaluation of the project. In December 2010, the FHWA and OEA determined that no supplemental environmental review would be required and that the same 3 environmental conditions should be imposed. After considering the entire record, including both the transportation aspects of the petition and the potential environmental issues, the Board granted the requested construction and operation exemption in a decision served today, subject to compliance with the environmental mitigation measures listed in the Appendix to the decision. Petitions to reopen must be filed by April 26, 2011. Board decisions and notices are available on our Web site at http:// www.stb.dot.gov. Decided: March 30, 2011. By the Board, Chairman Elliott and Commissioner Mulvey. Jeffrey Herzig, Clearance Clerk. [FR Doc. 2011–8158 Filed 4–5–11; 8:45 am] BILLING CODE 4915–01–P U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION Notice of Open Public Hearing U.S.-China Economic and Security Review Commission. ACTION: Notice of open public hearing— April 13, 2011 Washington, DC. AGENCY: Notice is hereby given of the following hearing of the U.S.-China Economic and Security Review Commission. Name: William A. Reinsch, Chairman of the U.S.-China Economic and Security Review Commission. The Commission is mandated by Congress to investigate, assess, and report to Congress annually on ‘‘the national security implications of the economic relationship between the United States and the People’s Republic of China.’’ Pursuant to this mandate, the Commission will hold a public hearing in Washington, DC on April 13, 2011, to address ‘‘China’s Current and Emerging Foreign Policy Priorities.’’ Background: This is the fifth public hearing the Commission will hold during its 2011 report cycle to collect input from leading academic, industry, and government experts on national security implications of the U.S. bilateral trade and economic relationship with China. The April 13 hearing will examine emerging issues and new interest groups in Chinese foreign policy, as well as China’s relationships with select countries of concern to the United States. The April 13 hearing will be co-chaired by Commissioners Carolyn Bartholomew and Peter Brookes. Any interested party may file a written statement by April 13, 2011, by mailing to the contact below. A portion of each panel will include a question and answer period between the Commissioners and the witnesses. Transcripts of past Commission public hearings may be obtained from the USCC Web Site http:// www.uscc.gov. Date and Time: Wednesday, April 13, 2011, 8:40 a.m. to 3:30 p.m. Eastern Standard Time. A detailed agenda for the hearing will be posted to the Commission’s Web Site at http:// www.uscc.gov as soon as available. ADDRESSES: The hearing will be held on Capitol Hill in Room 216 of the Hart SUMMARY: Senate Office Building, located at Constitution Avenue and 2nd Street, NE., in Washington, DC 20002. Public seating is limited to about 50 people on a first come, first served basis. Advance reservations are not required. Any member of the public seeking further information concerning the hearing should contact Michael Danis, Executive Director for the U.S.-China Economic and Security Review Commission, 444 North Capitol Street, NW., Suite 602, Washington DC 20001; phone: 202–624–1407, or via e-mail at contact@uscc.gov. FOR FURTHER INFORMATION CONTACT: Authority: Congress created the U.S.-China Economic and Security Review Commission in 2000 in the National Defense Authorization Act (Pub. L. 106–398), as amended by Division P of the Consolidated Appropriations Resolution, 2003 (Pub. L. 108–7), as amended by Public Law 109–108 (November 22, 2005). Dated: March 31, 2011. Michael Danis, Executive Director, U.S.-China Economic and Security Review Commission. [FR Doc. 2011–8078 Filed 4–5–11; 8:45 am] BILLING CODE 1137–00–P DEPARTMENT OF VETERANS AFFAIRS Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board; Notice of Meetings The Department of Veterans Affairs gives notice under the Public Law 92– 463 (Federal Advisory Committee Act) that the panels of the Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board will meet from 8 a.m. to 5 p.m. on the dates indicated below: mstockstill on DSKH9S0YB1PROD with NOTICES Panel Date(s) Hematology ............................................................................................... Surgery ..................................................................................................... Endocrinology-B ........................................................................................ Endocrinology-A ........................................................................................ Infectious Diseases-B ............................................................................... Nephrology ................................................................................................ Neurobiology-A ......................................................................................... Neurobiology-E ......................................................................................... Pulmonary Medicine ................................................................................. Cellular & Molecular Medicine .................................................................. Epidemiology ............................................................................................ Mental Hlth & Behav Sci-B ....................................................................... Mental Hlth & Behav Sci-A ....................................................................... Neurobiology-C ......................................................................................... Oncology ................................................................................................... May 25, 2011 ................................. May 25, 2011 ................................. May 26, 2011 ................................. June 2–3, 2011 .............................. June 2, 2011 .................................. June 2, 2011 .................................. June 2–3, 2011 .............................. June 3, 2011 .................................. June 3, 2011 .................................. June 6, 2011 .................................. June 7, 2011 .................................. June 7–8, 2011 .............................. June 8–9, 2011 .............................. June 8–10, 2011 ............................ June 9–10, 2011 ............................ VerDate Mar<15>2010 16:52 Apr 05, 2011 Jkt 223001 PO 00000 Frm 00160 Fmt 4703 Sfmt 4703 E:\FR\FM\06APN1.SGM Location L’Enfant Plaza Hotel. Crowne Plaza DC/Silver L’Enfant Plaza Hotel. L’Enfant Plaza Hotel. Hamilton Crowne Plaza. Crowne Plaza DC/Silver Crowne Plaza DC/Silver Crowne Plaza DC/Silver Crowne Plaza DC/Silver Crowne Plaza DC/Silver VA Central Office.* L’Enfant Plaza Hotel. L’Enfant Plaza Hotel. Crowne Plaza DC/Silver L’Enfant Plaza Hotel. 06APN1 Spring. Spring. Spring. Spring. Spring. Spring. Spring. 19189 Federal Register / Vol. 76, No. 66 / Wednesday, April 6, 2011 / Notices Panel Date(s) Immunology .............................................................................................. Infectious Diseases-A ............................................................................... Cardiovascular Studies ............................................................................. Neurobiology-D ......................................................................................... Clinical Research Program ....................................................................... Gastroenterology ...................................................................................... June June June June June June Location 9, 2011 .................................. 9, 2011 .................................. 10, 2011 ................................ 10, 2011 ................................ 13, 2011 ................................ 13, 2011 ................................ L’Enfant Plaza Hotel. L’Enfant Plaza Hotel. Crowne Plaza DC/Silver Spring. Crowne Plaza DC/Silver Spring. VA Central Office.* L’Enfant Plaza Hotel. The addresses of the hotels and VA Central Office are: Plaza Washington DC/Silver Spring, 8777 Georgia Avenue, Silver Spring, MD. Hamilton Crowne Plaza, 1001–14th Street, NW., Washington, DC. L’Enfant Plaza Hotel, 480 L’Enfant Plaza, SW., Washington, DC. * VA Central Office, 131 M Street, NE., Washington, DC. * Teleconference. mstockstill on DSKH9S0YB1PROD with NOTICES The purpose of the Merit Review Board is to provide advice on the scientific quality, budget, safety and mission relevance of investigatorinitiated research proposals submitted for VA merit review consideration. Proposals submitted for review by the Board involve a wide range of medical specialties within the general areas of biomedical, behavioral and clinical science research. The panel meetings will be open to the public for approximately one hour at the start of each meeting to discuss the general status of the program. The remaining portion of each panel meeting will be closed to the public for the review, discussion, and evaluation of initial and renewal research proposals. The closed portion of each meeting involves discussion, examination, reference to staff and consultant critiques of research proposals. During this portion of each meeting, discussion and recommendations will deal with qualifications of personnel conducting the studies, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy, as well as research information, the premature disclosure of which could significantly frustrate implementation of proposed agency action regarding such research proposals. As provided by subsection 10(d) of Public Law 92–463, as amended, closing portions of these panel meetings is in accordance with 5 U.S.C., 552b(c)(6) and (9)(B). Those who plan to attend or would like to obtain a copy of minutes of the panel meetings and rosters of the members of the panels should contact VerDate Mar<15>2010 16:52 Apr 05, 2011 Jkt 223001 LeRoy G. Frey, PhD, Chief, Program Review (121F), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420 at (202) 443– 5674. Dated: March 31, 2011. By Direction of the Secretary. William F. Russo, Director of Regulations Management, Office of General Counsel. [FR Doc. 2011–8114 Filed 4–5–11; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that a meeting of the Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee will be held on April 25, 2011, at The Ritz-Carlton Hotel, 1150 22nd Street, NW., Washington, DC. The meeting is scheduled to begin at 9 a.m. and end at 3 p.m. The Committee advises the Chief Research and Development Officer through the Director of the Clinical Science Research and Development Service on the relevance and feasibility of proposed projects and the scientific validity and propriety of technical PO 00000 Frm 00161 Fmt 4703 Sfmt 9990 details, including protection of human subjects. The session will be open to the public for approximately 30 minutes at the start of the meeting for the discussion of administrative matters and the general status of the program. The remaining portion of the meeting will be closed to the public for the Committee’s review, discussion and evaluation of research and development applications. During the closed portion of the meeting, discussions and recommendations will deal with qualifications of personnel conducting the studies, staff and consultant critiques of research proposals and similar documents and the medical records of patients who are study subjects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. As provided by section 10(d) of Public Law 92–463, as amended, closing portions of this meeting is in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B). Those who plan to attend should contact Dr. Grant Huang, Deputy Director, Cooperative Studies Program (125), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, or e-mail at grant.huang@va.gov or phone at (202) 443–5600. Dated: March 31, 2011. By Direction of the Secretary. William F. Russo, Director of Regulations Management, Office of General Counsel. [FR Doc. 2011–8115 Filed 4–5–11; 8:45 am] BILLING CODE P E:\FR\FM\06APN1.SGM 06APN1

Agencies

[Federal Register Volume 76, Number 66 (Wednesday, April 6, 2011)]
[Notices]
[Pages 19188-19189]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8114]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review 
Board; Notice of Meetings

    The Department of Veterans Affairs gives notice under the Public 
Law 92-463 (Federal Advisory Committee Act) that the panels of the 
Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review Board 
will meet from 8 a.m. to 5 p.m. on the dates indicated below:

----------------------------------------------------------------------------------------------------------------
                Panel                          Date(s)                              Location
----------------------------------------------------------------------------------------------------------------
Hematology...........................  May 25, 2011...........  L'Enfant Plaza Hotel.
Surgery..............................  May 25, 2011...........  Crowne Plaza DC/Silver Spring.
Endocrinology-B......................  May 26, 2011...........  L'Enfant Plaza Hotel.
Endocrinology-A......................  June 2-3, 2011.........  L'Enfant Plaza Hotel.
Infectious Diseases-B................  June 2, 2011...........  Hamilton Crowne Plaza.
Nephrology...........................   June 2, 2011..........  Crowne Plaza DC/Silver Spring.
Neurobiology-A.......................  June 2-3, 2011.........  Crowne Plaza DC/Silver Spring.
Neurobiology-E.......................  June 3, 2011...........  Crowne Plaza DC/Silver Spring.
Pulmonary Medicine...................  June 3, 2011...........   Crowne Plaza DC/Silver Spring.
Cellular & Molecular Medicine........  June 6, 2011...........   Crowne Plaza DC/Silver Spring.
Epidemiology.........................  June 7, 2011...........  VA Central Office.*
Mental Hlth & Behav Sci-B............  June 7-8, 2011.........  L'Enfant Plaza Hotel.
Mental Hlth & Behav Sci-A............  June 8-9, 2011.........  L'Enfant Plaza Hotel.
Neurobiology-C.......................  June 8-10, 2011........  Crowne Plaza DC/Silver Spring.
Oncology.............................  June 9-10, 2011........  L'Enfant Plaza Hotel.

[[Page 19189]]

 
Immunology...........................  June 9, 2011...........  L'Enfant Plaza Hotel.
Infectious Diseases-A................  June 9, 2011...........  L'Enfant Plaza Hotel.
Cardiovascular Studies...............  June 10, 2011..........  Crowne Plaza DC/Silver Spring.
Neurobiology-D.......................  June 10, 2011..........  Crowne Plaza DC/Silver Spring.
Clinical Research Program............  June 13, 2011..........  VA Central Office.*
Gastroenterology.....................  June 13, 2011..........  L'Enfant Plaza Hotel.
----------------------------------------------------------------------------------------------------------------
The addresses of the hotels and VA Central Office are:
Plaza Washington DC/Silver Spring, 8777 Georgia Avenue, Silver Spring, MD.
Hamilton Crowne Plaza, 1001-14th Street, NW., Washington, DC.
L'Enfant Plaza Hotel, 480 L'Enfant Plaza, SW., Washington, DC.
* VA Central Office, 131 M Street, NE., Washington, DC.
* Teleconference.

    The purpose of the Merit Review Board is to provide advice on the 
scientific quality, budget, safety and mission relevance of 
investigator-initiated research proposals submitted for VA merit review 
consideration. Proposals submitted for review by the Board involve a 
wide range of medical specialties within the general areas of 
biomedical, behavioral and clinical science research.
    The panel meetings will be open to the public for approximately one 
hour at the start of each meeting to discuss the general status of the 
program. The remaining portion of each panel meeting will be closed to 
the public for the review, discussion, and evaluation of initial and 
renewal research proposals.
    The closed portion of each meeting involves discussion, 
examination, reference to staff and consultant critiques of research 
proposals. During this portion of each meeting, discussion and 
recommendations will deal with qualifications of personnel conducting 
the studies, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy, as well as research 
information, the premature disclosure of which could significantly 
frustrate implementation of proposed agency action regarding such 
research proposals.
    As provided by subsection 10(d) of Public Law 92-463, as amended, 
closing portions of these panel meetings is in accordance with 5 
U.S.C., 552b(c)(6) and (9)(B). Those who plan to attend or would like 
to obtain a copy of minutes of the panel meetings and rosters of the 
members of the panels should contact LeRoy G. Frey, PhD, Chief, Program 
Review (121F), Department of Veterans Affairs, 810 Vermont Avenue, NW., 
Washington, DC 20420 at (202) 443-5674.

    Dated: March 31, 2011.

    By Direction of the Secretary.
William F. Russo,
Director of Regulations Management, Office of General Counsel.
[FR Doc. 2011-8114 Filed 4-5-11; 8:45 am]
BILLING CODE 8320-01-P